Operating income increased 62.7%
Operating income changed +62.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed +62.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Current assets changed -40.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Shares outstanding changed -83.1% from the comparable as-filed period. The change ranks at the 80th percentile of 5 prior comparable changes.
Trade receivables changed +94.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Cash & equivalents changed -54.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Research & development changed -77.0% from the comparable as-filed period.
Working capital changed -52.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.